French Agency Continues Recommending Valneva’ IXCHIQ Vaccine For Ages 18-64, Suspends For Seniors

(RTTNews) – Valneva SE (VALN) announced that France’s national public health agency, the Haute Autorité de Santé (HAS), has updated its recommendation for use of Valneva’s single-dose chikungunya vaccine IXCHIQ for the prevention of disease caused by the chikungunya virus (CHIKV)

admin